OSE Immunotherapeutics, a biotechnology company that develops immunotherapies for cancer and autoimmune diseases, and One2Treat, a fast-growing technology company transforming …
Looking towards 2026, clinical trial teams continue to face challenges surrounding recruitment and retention, while many patients continue to confront …
Gilead Sciences’ human immunodeficiency virus (HIV) single-tablet combination antiretroviral therapy (ART) has proven non-inferior to standard of care (SoC) in a …
With the role of automating patient randomisation and supply management, IRT is a critical backbone for trial execution, yet it …
The Asia-Pacific (APAC) clinical trial landscape is undergoing a shift, with clinical trial activity rising two to three times faster …
Sanofi’s experimental drug for multiple sclerosis (MS) has been hit with another US regulatory delay, a setback compounded by disappointing …
InnoCare Pharma’s orelabrutinib is progressing to a pivotal trial in systemic lupus erythematosus (SLE) after the drug displayed encouraging activity …
Alphyn Biologics has completed $25m in a Series B funding round to support the global Phase IIb trial of its …
Anova Enterprises has launched the AnovaOS software-as-a-service (SaaS) platform, a new AI-based patient matching solution for clinical trials. The solution is …
Rezolute’s stock has crashed after its only pipeline product flopped in a Phase III trial. In the sunRIZE trial (NCT06208215), ersodetug, …
Eli Lilly’s triple glucagon agonist has achieved up to 28.7% weight loss in a Phase III trial. In the TRIUMPH-4 trial, …
For years, one of the biggest barriers to effectively implementing artificial intelligence (AI) into clinical trial data management has been …
The US Food and Drug Administration (FDA) has granted clearance to Prilenia Therapeutics and Ferrer to commence a Phase III …
Lindus Health and Quotient Sciences have entered a strategic collaboration to support biotech and pharmaceutical sponsors with subject recruitment for …
At the American Society of Hematology (ASH) Annual Meeting 2025, held in Orlando, Florida, from 6 to 9 December, updated …
